Clinical Trial Detail

NCT ID NCT03526926
Title A Post-Marketing Observational Study of VYXEOS
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Jazz Pharmaceuticals
Indications

acute myeloid leukemia

Therapies

CPX-351

Age Groups: adult senior

No variant requirements are available.